Pioz 15 Mg

Pioz 15 Mg (Pioglitazone)

Active Ingredient Pioglitazone/Metformin
Indication Type 2 diabetes
Manufacturer USV Pvt. Ltd.
Strength:- 15mg
Packaging 10 tablet er in 1 strip

Description

Pioz 15 Mg tablet is a type of anti-diabetic medication. It is prescribed to individuals who have type 2 diabetes for proper treatment and management. Type 2 diabetes is a condition in which the body fails to make a sufficient amount of insulin, or the insulin that is made in the body does not work the way it should. Individuals who are given this medication should be careful with their diet and eat a healthy diet along with proper exercise.

Pioz 15 Mg Tablet works by controlling and managing the blood sugar levels in the body. This medication may be prescribed alone or can be given along with some other medication. Pioz 15 Mg Tablet helps prevent the risk of serious complications that may occur due to diabetes, such as eye damage and kidney damage.

Pioz 15 Mg Tablet must not be taken if you are a patient of type 1 diabetes mellitus or diabetic ketoacidosis. Inform your doctor if you are a heart or thyroid patient before you start treatment with Pioz 15 Mg Tablet. If you have any hormonal conditions, inform your doctor beforehand.

Do not stop taking Pioz 15 Mg Tablet until your doctor says so, as stopping this medication without your doctor’s advice may elevate your blood sugar levels abnormally, leading to an increased risk of severe health complications like blindness, kidney damage, or loss of limbs.

Pioz 15 Mg Tablet has Piolitazone as its main active ingredient. This drug belongs to thiazolidinedione (TZD) or as, also known as Glitazones. Pioz 15 Mg Tablet or Pioz 30 Mg is given for the treatment of a non-insulin-dependent type of diabetes called type 2 diabetes. Pioz 15 Mg Tablet works by improving how our body responds to the insulin hormone. Insulin hormone is essential to regulate our blood glucose/ blood sugar levels. Pioz 15 Mg Tablet prevents the rising of blood sugar levels after meals. 

Pioz 15 Mg Tablet helps lower blood glucose levels. Thus, this medication helps manage type 2 diabetes. It helps effectively improve how the body reacts to insulin. Pioz 15 Mg Tablet also reduces the risk of other diabetes-related health complications like nerve damage, kidney damage, or eye problems like blindness. 

Pioz 15 Mg Tablet is used to treat non-insulin-dependent diabetes or type 2 diabetes.

Pioz 15 Mg Tablet may interact with the antibiotic rifampicin and anti-diabetic medication gemfibrozil. Hence, it is essential that before you start treatment with Pioz 15 Mg Tablet, you inform your doctor if you are taking these medications.

Most of the side effects of Pioz 15 Mg Tablet do not require any immediate medical attention. These side effects may go away or get better as the body starts adjusting to the medication. However, if you have severe side effects from Pioz 15 Mg Tablet or if it does not get better with time, consult your doctor.

The various side effects of the Pioz 15 Mg Tablet include the following,

Pioz 15 Mg Tablet is to be stored in a dry and cool place. Keep Pioz 15 Mg Tablet away from sunlight.

Pioz 15 Mg Tablet with or without food, just as your doctor prescribes it. Pioz 15 Mg Tablet is to be swallowed as a whole with water. Do not chew, break, or crush Pioz 15 Mg Tablet. 

Pioz 15 Mg Tablet is used by individuals having non-insulin dependent diabetes. It is to be taken only when a healthcare professional prescribes it. Individuals taking Pioz 15 Mg Tablet need to get their blood sugar levels regularly monitored.

This medication is not to be taken without informing the doctor in case of pregnancy, breastfeeding, hormonal disorders, heart disease, liver problems, or kidney problems. Taking Pioz 15 Mg Tablet along with a good diet and regular exercising can help prevent the risk of severe diabetes-related complications like vision loss, kidney damage, loss of limbs, or nerve damage.

Reviews

There are no reviews yet.

Be the first to review “Pioz 15 Mg (Pioglitazone)”

Your email address will not be published. Required fields are marked *